(Q37858877)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

review article

1 reference

title

Gene expression profiling in MDS and AML: potential and future avenues (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Jacqueline Boultwood

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sergio Ferrari

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Krzysztof Giannopoulos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

Jesus Maria Hernandez Rivas

26 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Bo Torben Porse

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Enrico Tagliafico

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Ken I. Mills

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

A Kohlmann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

M Morgan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

C M Zwaan

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

J Wainscoat

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

M M Van den Heuvel-Eibrink

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

L Bullinger

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

29 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

909-920

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

Myelodysplastic syndromes: the complexity of stem-cell diseases

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Current status of gene expression profiling in the diagnosis and management of acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Prognostically useful gene-expression profiles in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

KIT mutations confer a distinct gene expression signature in core binding factor leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Gene expression profiling of pediatric acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Age-associated difference in gene expression of paediatric acute myelomonocytic lineage leukaemia (FAB M4 and M5 subtypes) and its correlation with prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

DNA micro-array analysis of myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Treatment of AML in biological subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (RARS) and effects of G-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Acute promyelocytic leukemia: from highly fatal to highly curable

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Acute promyelocytic leukemia: a paradigm for differentiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

MN1 affects expression of genes involved in hematopoiesis and can enhance as well as inhibit RAR/RXR-induced gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

FUS expression alters the differentiation response to all-trans retinoic acid in NB4 and NB4R2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

21 January 2018

Acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

A genomic strategy to elucidate modules of oncogenic pathway signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Identification of AML1-ETO modulators by chemical genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Leukaemogenesis: more than mutant genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

MicroRNA expression in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Mammalian microRNAs predominantly act to decrease target mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Whole genome scanning as a cytogenetic tool in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Disclosure of Candidate Genes in Acute Myeloid Leukemia With Complex Karyotypes Using Microarray-Based Molecular Characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Acquired copy number alterations in adult acute myeloid leukemia genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Epigenetics in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Quantitative DNA methylation predicts survival in adult acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Chromatin maps, histone modifications and leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Proteomics and the haematologist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Quantitative proteomics analysis demonstrates post-transcriptional regulation of embryonic stem cell differentiation to hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Transcriptomic and proteomic approach to studying SNX-2112-induced K562 cells apoptosis and anti-leukemia activity in K562-NOD/SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

A tagging-via-substrate approach to detect the farnesylated proteome using two-dimensional electrophoresis coupled with Western blotting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Functional proteomic profiling of AML predicts response and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Integrated genomic and proteomic analyses of gene expression in Mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Molecular characterization of AML with ins(21;8)(q22;q22q22) reveals similarity to t(8;21) AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Dysregulated gene expression networks in human acute myelogenous leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

The leukemic stem cell niche: current concepts and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

A conceptual framework for the identification of candidate drugs and drug targets in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

Molecular characterization of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

7 January 2021

Gene expression profiling in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

7 January 2021

Pattern robustness of diagnostic gene expression signatures in leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

7 January 2021

Intraplatform reproducibility and technical precision of gene expression profiling in 4 laboratories investigating 160 leukemia samples: the DACH study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

7 January 2021

Global approach to the diagnosis of leukemia using gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

7 January 2021

An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

7 January 2021

Gene Expression–Based Classification As an Independent Predictor of Clinical Outcome in Juvenile Myelomonocytic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

7 January 2021

Childhood acute myelogenous leukaemia: association between PRAME, apoptosis- and MDR-related gene expression

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

7 January 2021

Gene expression profiling in the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

7 January 2021

Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

7 January 2021

The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

7 January 2021

Gene expression profiling of CD34+cells in patients with the 5q− syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

7 January 2021

The molecular basis of leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

7 January 2021

Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

7 January 2021

Identification of PML/RARalpha fusion gene transcripts that showed no t(15;17) with conventional karyotyping and fluorescent in situ hybridization.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.48

7 January 2021

Identifiers

DOI

10.1038/LEU.2011.48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445077%20AND%20SRC:MED&resulttype=core&format=json

release_3wxqrh32cff6phf5azsuchcdoy

26 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3wxqrh32cff6phf5azsuchcdoy

24 November 2022

mapped directly with Wikidata item

1 reference